Centre for Commercialization of Regenerative Medicine: PHC and CCRM collaborate to develop primary Tcell expansion culture processes to enhance efficiency and improve cell quality

PHC Corporation, a Japanese subsidiary of PHC Holdings Corporation, a global healthcare company, has signed a Master Collaboration Agreement with CCRM, a global, public─private partnership headquartered in